Novartis Oncology CTO Salaries in Wilmington, DE | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology CTO Salaries in Wilmington, DE

The average Novartis Oncology CTO in Wilmington, DE earns an estimated $205,558 annually. Novartis Oncology's CTO compensation is $20,031 less than the US average for a CTO.

In Wilmington, DE, The Engineering Department at Novartis Oncology earns $1,831 more on average than the Marketing Department.

Last updated 3 years ago.

$61k
$107k
$154k
$200k
$5.20M
$205,558
Average Compensation
$205,558
avg. base

CTO Salaries at Novartis Oncology

In Wilmington, DE, CTOs earn $3,542 more than Group Engineering Managers, and $9,343 less than Directors of Engineering.

Director of Engineering
$215k*
Group Engineering Manager
$202k*
Principal Engineer
$155k*
Sales Engineer
$149k*
Data Scientist
$135k*
Engineering Manager
$132k*
DevOps
$119k*
Mobile Developer
$117k*
Lead Engineer
$115k*
Scrum Master
$112k*
Senior Developer
$109k*
QA
$97k*
Senior QA
$86k*
Developer
$81k*
Jr Developer
$72k*
* estimated salary

Compensation at Novartis Oncology by Department

In Wilmington, DE, The Engineering Department averages $1,831 more than the Marketing Department, and $129 less than the Business Development Department

Business Development
$127,462 Avg. total comp.
+$129
Engineering
$127,333 Avg. total comp.
Marketing
$125,502 Avg. total comp.
-$2k

CTO Compensation by Gender (All Companies)

The average female CTO at companies similar size to Novartis Oncology reported making $300,000, while the average male CTO at similar sized companies reported making $360,212.

CTO Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander CTO at companies similar size to Novartis Oncology reported making $443,111, while the average African American/Black CTO at similar sized companies reported making $185,000.

How CTOs at Novartis Oncology Rate Their Compensation

The majority of CTOs at Novartis Oncology believe they're not compensated fairly. 100% of CTOs at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company